substrate for SR than L-serine and also an inhibitor of D-serine synthesis. Inhibition of SR provides a new strategy to selectively decrease the NMDAR coactivation and this may be useful in conditions in which overstimulation of NMDARs plays a pathological role in causing cerebrovascular ischemia.
Several plasma biomarkers such as high-sensitivity C-reactive proteins (hs-CRPs), low-density lipoprotein-cholesterol (LDL-C), lipoprotein-associated phospholipase A2, myeloperoxidase, oxidized LDL, lipoprotein (a), and isoprostanes are emerging non-specific biomarkers. 7 Thus, it is essential to have a very specific affordable biomarker for the early detection of stroke.
SR, D-serine, and blood vessels
SR is most active as a non-covalent dimer containing one or more free sulphydryls in the enzyme's active or modulatory site, 8 and this gave rise to the possibility of SR sensitivity to oxidative stress, which is the underlying basis of stroke 9 ( Figure 1 ) acting through the astrocytic network to regulate the cerebrovascular system. 10 Astrocytes express receptors for many neurotransmitters such as glutamate and ATP and their activation results in internal calcium oscillation and the accumulation of arachidonic acid (AA) causing both vasodilatory and vasoconstrictive actions through at least 2 of its metabolic pathways, that is, cyclooxygenase-2 (COX)-dependent accumulation of prostaglandin E2 (PGE2) leads to vasodilation, whereas the diffusion of AA to the smooth muscle, which contains high levels of cytochrome P450 4F2 (CPY4F2), is responsible for the conversion of AA into 20-hydroxyeicosatetraenoic acid (20-HETE) and causes vasoconstriction. Whereas these 2 opposing actions appear to be conflicting, because both have been observed to occur in vivo, the challenge is to identify the conditions that select for the respective actions ( Figure 1 ).
Astrocytes are also considered to play an important role in brain pH homeostasis. Astrocyte processes surround synapses and possess transporters for the uptake of various neurotransmitters, including glutamate, 11 mainly through ionotropic NMDAR which needs D-serine for its activation. We hypothesized that altered D-serine concentration is associated with vascular pathology and as a coagonist of NMDAR; it plays an important role in the metabolism of excitatory amino acid glutamate through NMDAR. The pathophysiology of cerebrovascular disorders such as stroke has not been fully understood, but overstimulation of NMDAR appears to play a central role. This is of particular interest because D-serine concentration might be pharmacologically manipulated as the synthesizing and metabolizing enzymes of D-serine are known. We hypothesized that D-serine (product of SR) as a coagonist of NMDAR plays an important role in vascular pathologies such as stroke. We first tested our hypothesis in an animal model.
Materials and Methods

In vitro pilot study on rodents
Animal studies were approved by the Animal Ethics Research Committee, Faculty of Health Sciences, University of Brunei Darussalam. A total of 16 Wistar rats (200-250 g) were obtained for each sham and stroke model. Four rats per time point in both experimental and sham groups were anesthetized intraperitoneally with chloral hydrate (500 mg/kg). A skin incision was made between the eye orbit and ear to make the middle cerebral artery (MCA) visible. The MCA was coagulated by bipolar diathermy using a Gyrus Plasma Kinetic device to occlude MCA and the incision was sutured. For sham experiments, the MCA was exposed in the same manner as described above, but was not occluded. Animals from both the control (sham) and the occluded middle cerebral artery (OMCA) groups were decapitated at different time intervals of 1 hour and 4, 8, and 15 days. Both ischaemic (ipsilateral to surgery) and non-ischaemic (contralateral to surgery) cortices from the same rat were dissected.
High-performance liquid chromatography (HPLC) was used for the detection of L-serine and D-serine in the normal and OMCA brains. The sample preparation requires only homogenization in perchloric acid and centrifugation at 20 400g for 10 minutes before injection onto the column. The mixture was derivatized with a LiChrosorb RP-18 (10pm (polar mode)) column and a mobile phase consisting of a phosphate (NaH 2 PO 4 , 0.1 M)-methanol mixture with octylsulphonate (2.6 X M) at pH 8.35. For normal rats, L-serine was 576 ± 102 mmol/g of wet tissue and D-serine 69 ± 22 mmol/g of wet tissue; for stroke model rats on day 7 the concentration of L-serine in the ipsilateral (I) cortex obtained by HPLC was 745 ± 108 mmol/g of wet tissue and D-serine on day 7 and same side of occlusion was 235 ± 44 mmol/g of wet tissue.
Statistical analysis. Data are presented as the mean ± SEM. Comparisons between 2 groups were statistically made using the Student's t-test. Multiple comparisons were evaluated using an analysis of variance (ANOVA) followed by the Newman-Keuls multiple comparison test, indicating a significant (P < .05) increase of D-serine concentration in OMCA rodents (Table 1) . We observed higher values for both D-serine and L-serine, within an hour after the occlusion of medial cerebral artery, on both ipsilateral (I) and contralateral (C) sides. Then the concentration of L-serine dropped back to its original value within a week. In 15 days, the concentration of D-serine declines and that of L-serine increases indicating the exhaustion of SR activities. Table 1 suggests that the animal model of OMCA mimics stroke and the concentration of D-serine increases as a result of escalated SR activities. Hence, the cytotoxic effect of hyperactive NMDAR in the presence of its coagonist D-serine indicated an increase in SR activities before, during, and after the stroke.
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Animal studies were performed to see the effect of ischaemic brain (due to experimental occlusion of the medical cerebral artery) on the levels of L-serine and D-serine before measuring these chemicals in human subjects (suffering from transient ischaemic attacks [TIA] ) and their normal counterparts.
Pilot study in a cohort of humans
The cardiovascular system is essential for supplying oxygen and nutrition and for the exchange of gasses, and any obstruction in the system gives rise to multiple pathologies. The walls of the blood vessels of both cardiovascular and cerebrovascular systems are susceptible to thickening, impeding the blood flow and causing ischemia and tissue death of the brain, heart, and other vital organs. Thus, it is essential to find out the early markers of atherosclerosis, as this condition remains silent till the cerebral, coronary, renal, and peripheral artery diseases occur. This is a prospective case-control non-randomized study to find out the early markers of atherosclerosis. This study was performed after obtaining approval from the Human Ethic Committee, Raja Isteri Pengiran Anak Saleha (RIPAS) hospital, Ministry of Health Brunei Darussalam. A written informed consent was also obtained from each of the participants before running the biochemical tests and B-mode ultrasonography. Newly diagnosed TIA patients along with their age-and sex-matched healthy control subjects were recruited. There were 22 people in each group after screening them through the exclusion criteria of target organ damage after TIA such as stroke, heart failure, and kidney damage. The exclusion study was done using electroencephalography (EEG), electrocardiography (ECG), and renal function tests. Subjects with dyslipidaemia, diabetes, smokers, adrenal gland disease, and lung disease and pregnant and lactating subjects were also excluded. This information was obtained from their medical records.
To circumvent inter-observer variation, a single radiologist was assigned to perform all carotid examinations and was blinded to the status of all subjects. Measurements for carotid intima media thickness (CIMT) were repeated 3 times on each left and right carotid artery. To avoid any intra-observation differences, the average values for each set of 6 readings are represented as the mean ± SE for CIMT of each side (Table 2) . CIMT increment is correlated with blood pressure, blood cholesterol, blood sugar, and kidney markers ( Table 2) .
We explored the possibility of finding a blood marker which imitates the ultrasound results of blood vessels, as ultrasound is expensive and cannot be done routinely. We observed for the first We further examined the association between the concentrations of D-serine in the blood with the IMT of coronary vessels and found a direct relationship between them. HPLC was used to separate and quantify total serine, L-serine, and D-serine in both control and TIA patients. Thus, the measurement of D-serine will accurately reflect changes in SR levels and activity. Participants with normal levels (2.38 μmol/L) of D-serine have a CIMT of about 0.65 mm compared with The * symbol towards the lumen represents the interface between the lumen and tunica intima of the blood vessel, whereas lower * exhibits the boundaries between the media and adventitia layers. These measurements are considered to be highly reliable markers for the status of atherosclerosis and will be very beneficial for correct diagnosis especially in asymptomatic conditions.
at-risk individuals with higher levels (3.808 μmol/L) of D-serine, where the CIMT was greater than 1 mm. We found that both total serine and L-serine were low in TIA patients as compared with their normal counterparts, whereas D-serine concentration in patients with TIA was significantly higher (P < .01) than that in their healthy counterparts ( Table 3 ), suggesting that the activity of SR may have increased in TIA patients.
Imaging data showed that the increase in the CIMT was highly correlated with the activity of SR and the concentration of its product D-serine.
The CIMT images ( Figure 2 ) were obtained using B-mode ultrasonography. We found that the control subjects with a low concentration of D-serine had CIMT of less than 1 mm (Figure 2A) , both of which increased with time ( Figure 2B ), whereas TIA patients with a CIMT value of 2.2 mm had a higher concentration of D-serine ( Figure 2C ). In some patients, with further increase in the concentration of D-serine, we observed higher values of IMT (5.4 mm). This increase in thickness could be due to the presence of calcified plaque in combination with intima hyperplasia ( Figure 2D ). Power Doppler recordings are shown in Figure 2 .
Increasing CIMT over time correlates with increasing atherosclerosis, whereas a decrease in CIMT is indicative of atherosclerotic regression. In our experiments in humans, we found a direct relationship between increasing CIMT and elevating D-serine levels.
Significance and future directions
In total, 80 million adults (1 in 3 people) are affected by cardio/ cerebrovascular diseases. Myocardial infarctions (MIs) and strokes occur because of atherosclerotic plaque formation, but unfortunately atherosclerosis remains asymptomatic, which leads to delay in treatment until it is too late. Our data indicate that there is a significant increase in the levels of D-serine which correlates with increased concentration and activity of SR in subjects from the 'at-risk group' (ie, individuals with more than 1 mm of CIMT), compared with their healthy counterparts. Thus, the measurement of D-serine may accurately reflect changes in SR levels and activity. Participants with normal levels (2.38 µmol/L) of D-serine had a CIMT of about 0.65 mm compared with at-risk individuals with higher levels (3.808 µmol/L) of D-serine, where the CIMT was greater than 1 mm.
Further studies are needed in a larger cohort to validate the exciting findings of our preliminary biochemical data supported by imaging, demonstrating that the activity of SR and the concentration of its product D-serine are correlated with the IMT.
